The International Testing Agency has announced the provisional suspension of the Paralympic cyclist, who tested positive for EPO.
The International Testing Agency (ITA) made public, this Thursday, October 29, 2026, the provisional suspension of French cyclist Thomas Peyroton-Dartet. Paralympic champion of the C3 time trial in 2024, the 41-year-old athlete is subject to disciplinary proceedings after an abnormal test revealed the presence of EPO in his system.
According to information provided by the ITA, the test in question was carried out as part of the fight against doping. EPO, a synthetic hormone, is on the list of prohibited substances of the World Anti-Doping Agency. This substance is notably used to improve endurance and recovery, making it a sought-after product in disciplines requiring prolonged effort such as cycling.
Thomas Peyroton-Dartet, who distinguished himself on the international stage by winning the Paralympic title in 2024, is therefore provisionally withdrawn from competition. This measure, effective immediately, comes while awaiting the final results of the analysis of the B sample and the review of his case by the competent authorities. The athlete has a period of time to present his observations and, if necessary, request a counter-analysis.
This announcement reignites the debate on anti-doping vigilance in Paralympic sport, often perceived as less exposed than Olympic sport. The ITA, which manages testing for many international federations, recalls that any violation of the rules is treated with the same rigor, regardless of the athlete's status. The ongoing procedure will determine the consequences, which can range from a simple warning to a suspension of several years.
In the meantime, the French Cycling Federation and the organizers of the competitions concerned have taken note of this decision. The rider, who has not yet reacted publicly, retains the presumption of innocence until the procedure has come to an end. The coming weeks will be decisive for the sporting future of the athlete, whose track record could be tarnished if the violation is confirmed.
According to information provided by the ITA, the test in question was carried out as part of the fight against doping. EPO, a synthetic hormone, is on the list of prohibited substances of the World Anti-Doping Agency. This substance is notably used to improve endurance and recovery, making it a sought-after product in disciplines requiring prolonged effort such as cycling.
Thomas Peyroton-Dartet, who distinguished himself on the international stage by winning the Paralympic title in 2024, is therefore provisionally withdrawn from competition. This measure, effective immediately, comes while awaiting the final results of the analysis of the B sample and the review of his case by the competent authorities. The athlete has a period of time to present his observations and, if necessary, request a counter-analysis.
This announcement reignites the debate on anti-doping vigilance in Paralympic sport, often perceived as less exposed than Olympic sport. The ITA, which manages testing for many international federations, recalls that any violation of the rules is treated with the same rigor, regardless of the athlete's status. The ongoing procedure will determine the consequences, which can range from a simple warning to a suspension of several years.
In the meantime, the French Cycling Federation and the organizers of the competitions concerned have taken note of this decision. The rider, who has not yet reacted publicly, retains the presumption of innocence until the procedure has come to an end. The coming weeks will be decisive for the sporting future of the athlete, whose track record could be tarnished if the violation is confirmed.
Advertisement
Source: Ouest-France